Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Hellstern

Showing results (11-20 of 83) with videos related to

Pageof 9
Sort By:
Beitrage Zur Infusionstherapie = Contributions to Infusion Therapy|January 1, 1990
[Hemostatic therapy in a patient with acquired von Willebrand disease and Waldenström disease with plasmapheresis and DDAVP]K Thies, U Budde, P Hellstern
Annals of Hematology|December 1, 1993
Inactivation of viruses in fresh-frozen plasmaJ U Wieding, P Hellstern, M Köhler
Vox Sanguinis|March 1, 2003
Prevalence of illicit drug use in plasmapheresis donorsF T Peters, H H Maurer, P Hellstern
Haemostasis|January 1, 1994
Plasminogen activator inhibitor 1 activity and lipoprotein(a) in nephropathic patients with non-insulin-dependent diabetes mellitus versus patients with nondiabetic nephropathyT Schleiffer, P Hellstern, M Freitag, et al.
Hamostaseologie|August 18, 2004
[Platelet function tests for monitoring of acetylsalicylic acid: clinical significance in antiplatelet treatment]H Haubelt, M Simon, Ch Anders, et al.
ZFA. Zeitschrift Fur Allgemeinmedizin|May 31, 1981
[Treatment of blood coagulation disorders with the vasopressin derivative DDAVP (Minirin)]M Köhler, P Hellstern, B Vief, et al.
Thrombosis and Haemostasis|August 20, 1986
Urokinase preparations: quality control and stability in solutionC Miyashita, M Köhler, P Hellstern, et al.
Thrombosis and Haemostasis|August 20, 1986
Plasma heparin-like activities after percutaneous application of a low molecular weight heparin in healthy subjectsB Rodemer, P Hellstern, E Wetzler, et al.
Vox Sanguinis|January 1, 1992
Manufacture and in vitro characterization of a solvent/detergent-treated human plasmaP Hellstern, H Sachse, H Schwinn, et al.
HNO|August 10, 2010
[Prophylaxis of venous thromboembolism and anticoagulation bridging. Strategies in otorhinolaryngology]J Deutsch, H Haubelt, P Hellstern, et al.
Pageof 9

Showing results (11-20 of 83) with videos related to

Sort By:
Pageof 9
Beitrage Zur Infusionstherapie = Contributions to Infusion Therapy|January 1, 1990
[Hemostatic therapy in a patient with acquired von Willebrand disease and Waldenström disease with plasmapheresis and DDAVP]K Thies, U Budde, P Hellstern
Annals of Hematology|December 1, 1993
Inactivation of viruses in fresh-frozen plasmaJ U Wieding, P Hellstern, M Köhler
Vox Sanguinis|March 1, 2003
Prevalence of illicit drug use in plasmapheresis donorsF T Peters, H H Maurer, P Hellstern
Haemostasis|January 1, 1994
Plasminogen activator inhibitor 1 activity and lipoprotein(a) in nephropathic patients with non-insulin-dependent diabetes mellitus versus patients with nondiabetic nephropathyT Schleiffer, P Hellstern, M Freitag, et al.
Hamostaseologie|August 18, 2004
[Platelet function tests for monitoring of acetylsalicylic acid: clinical significance in antiplatelet treatment]H Haubelt, M Simon, Ch Anders, et al.
ZFA. Zeitschrift Fur Allgemeinmedizin|May 31, 1981
[Treatment of blood coagulation disorders with the vasopressin derivative DDAVP (Minirin)]M Köhler, P Hellstern, B Vief, et al.
Thrombosis and Haemostasis|August 20, 1986
Urokinase preparations: quality control and stability in solutionC Miyashita, M Köhler, P Hellstern, et al.
Thrombosis and Haemostasis|August 20, 1986
Plasma heparin-like activities after percutaneous application of a low molecular weight heparin in healthy subjectsB Rodemer, P Hellstern, E Wetzler, et al.
Vox Sanguinis|January 1, 1992
Manufacture and in vitro characterization of a solvent/detergent-treated human plasmaP Hellstern, H Sachse, H Schwinn, et al.
HNO|August 10, 2010
[Prophylaxis of venous thromboembolism and anticoagulation bridging. Strategies in otorhinolaryngology]J Deutsch, H Haubelt, P Hellstern, et al.
Pageof 9